Sayed Ibrahim M, El-Mokhtar Mohamed A, Mahmoud Mahmoud Abdel Rahman, Elkhawaga Amal A, Gaber Shereen, Seddek Nermien H, Abdel-Wahid Lobna, Ashmawy Ahmed M, Alkareemy Enas Ahmed Reda
Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Department of Internal Medicine, Gastroenterology and Hepatology unit, Faculty of Medicine, Assiut University, Assiut, 71515, Egypt.
Infect Drug Resist. 2021 Jan 12;14:59-69. doi: 10.2147/IDR.S289766. eCollection 2021.
Hepatitis E virus (HEV) is an emerging infectious agent that causes acute hepatitis in developing and developed countries. Diagnosis of HEV infection has not been routinely done in Egyptian hospitals, and clinicians do not prescribe ribavirin (RBV) for acute hepatitis cases of unknown etiology (AHUE). We aimed to screen patients with AHUE for the presence of HEV markers and to determine the complications associated with HEV infection.
HEV markers (anti-HEV IgM, anti-HEV IgG, and HEV RNA) were assessed in patients with AHUE (n=300) admitted to Assiut University Hospitals. RT-qPCR was used to detect the viral load and sequencing analysis was carried out to determine the genotype of the detected viruses. Phylogenetic tree was constructed to evaluate the genetic relatedness between the isolates. Laboratory parameters and the outcomes of infection were determined.
Acute HEV infection (AHE) was detected in 30 out of 300 (10%) of AHUE patients. Anti-HEV IgM, HEV RNA, and anti-HEV IgG were reported in 83%, 50%, and 43% of the samples, respectively. HEV RNA load ranged from 5×10 IU/mL to 1.1×10 IU/mL. Sequencing of the isolated viruses revealed that five viruses belong to HEV-1 and one isolate belongs to HEV-3 with high homology to the virus recently isolated from the cow and goat milk in the Egyptian villages. Although previous reports showed that attenuated HEV isolates were circulating in Egypt, four out of 30 patients (13%) developed coagulopathy and hepatic encephalopathy and died due to fulminant hepatic failure (FHF) within 3-6 weeks of hospitalization. Age, malignancy, and a history of pre-existing liver diseases were a risky factor for FHF development.
AHE is common in Upper Egypt. Older patients with malignancy and/or a history of liver diseases are risky. HEV diagnosis and treatment become pivotal in Egyptian hospitals to reduce the fatality rate and they should start urgently and promptly.
戊型肝炎病毒(HEV)是一种新出现的感染因子,在发展中国家和发达国家均可引起急性肝炎。埃及医院尚未常规开展戊型肝炎病毒感染的诊断,临床医生也不会为病因不明的急性肝炎(AHUE)病例开具利巴韦林(RBV)。我们旨在筛查AHUE患者是否存在戊型肝炎病毒标志物,并确定与戊型肝炎病毒感染相关的并发症。
对入住阿斯尤特大学医院的300例AHUE患者进行了戊型肝炎病毒标志物(抗HEV IgM、抗HEV IgG和HEV RNA)评估。采用逆转录定量聚合酶链反应(RT-qPCR)检测病毒载量,并进行测序分析以确定检测到的病毒基因型。构建系统发育树以评估分离株之间的遗传相关性。确定实验室参数和感染结局。
300例AHUE患者中有30例(10%)检测到急性戊型肝炎病毒感染(AHE)。抗HEV IgM、HEV RNA和抗HEV IgG在样本中的报告率分别为83%、50%和43%。HEV RNA载量范围为5×10 IU/mL至1.1×10 IU/mL。对分离出的病毒进行测序显示,5种病毒属于HEV-1,1种分离株属于HEV-3,与最近在埃及村庄从牛奶中分离出的病毒具有高度同源性。尽管先前的报告显示埃及存在减毒的戊型肝炎病毒分离株,但30例患者中有4例(13%)发生凝血病和肝性脑病,并在住院3至6周内因暴发性肝衰竭(FHF)死亡。年龄、恶性肿瘤和既往肝病病史是发生FHF的危险因素。
AHE在上埃及很常见。患有恶性肿瘤和/或有肝病病史的老年患者风险较高。在埃及医院,戊型肝炎病毒的诊断和治疗对于降低死亡率至关重要,应紧急且迅速地开展。